Analysis of JB Hi-Fi, Judo Capital, Ramsey Health Care
![](https://www.sharecafe.com.au/wp-content/uploads/2024/06/fnn-459787.jpg)
Fund Manager Chris Pedersen discusses JB Hi-Fi, Judo Capital Holdings and Ramsey Health Care.
Read MoreFund Manager Chris Pedersen discusses JB Hi-Fi, Judo Capital Holdings and Ramsey Health Care.
Read MoreRamsay Health Care (ASX:RHC) had finally sold its Malaysian and Indonesian hospitals owned in partnership with Malaysian conglomerate Sime Darby to 5.7 billion ringgit or $A1.9 billion.
Read MorePolar opposite prognoses from a couple of our healthcare stocks on Thursday, with private hospital operator Ramsay looking rosy but nutritional supplement retailer Blackmores decidedly less so.
Read MoreMonday saw the death knell finally rung for two of the… shall we say, less professional business entanglements in recent memory – although we all know nothing is forever in M&A.
Read MoreShares in Ramsay Healthcare slumped on Tuesday as two deals thought to be in the hand vanished in a matter of days with only a brief explanation to the market and shareholders.
Read MoreThe broker maintains its $80 target price. The Hold rating is unchanged.
Read MoreTwo updates on Friday from unrelated sectors linked by a common theme as higher costs saw lower profits from online retailer Kogan and private hospital operator Ramsay Health Care.
Read MoreRamsay Health Care confirmed Wednesday morning that it is talking to a “consortium of financial investors” led by US private equity giant KKR about a buyout worth as much as $20.1 billion.
Read MoreBuy rating retained while the target price loses -$1 to $74.00.
Read MoreRamsay Healthcare has been made a $1.8 billion offer for its Asian hospital joint venture that would cover the debt recently used to buy a UK private healthcare group, with some left over.
Read MoreTarget rises to $67.69 from $65.10, Hold retained.
Read MoreLike so many companies this reporting season, private hospital operator Ramsay Health Care continued to battle Covid’s impact on staff, materials and business generally in the December half.
Read MoreNews today that Boral will return $3bn in capital to shareholders later this month, while Ramsay Healthcare announced the acquisition of UK mental health care provider Elysium.
Read MoreRamsay Healthcare has gone back to the UK private health sector with a very different and lower priced expansion idea, announcing a $1.4 billion purchase of Elysium Healthcare.
Read MoreShares in private hospitals operator Ramsay Health Care dropped as much as 7.3% yesterday after it revealed a surprise drop in its first-quarter after-tax profit to just $58.1 million.
Read MoreA big payout for Ramsay shareholders, but if the $1 billion-plus Spire takeover hadn’t been rejected by holders of the target company, would Ramsay have been anywhere near as generous?
Read MoreRamsay Healthcare’s big plunge into the UK private hospital sector has ended after shareholders in its target, Spire Healthcare rejected the deal.
Read MoreRamsay Health Care said in a statement to the ASX Tuesday that it has bumped its offer for UK healthcare company Spire from 2.40GBP to 2.50GBP to try and win the deal.
Ramsay said on Tuesday that it will now offer from 250 pence a share up from 240p.
Read MoreNeutral rating with a $70 target price maintained.
Read MoreInvestors reacted warily on Thursday to the surprise $1.8 billion takeover bid from private health group Ramsay Health Care for a UK private hospital operator.
Read MoreRamsay Health Care has cut interim dividend after reporting a Covid-hit set of figures for the six months to December, led by a 12.5% drop in net profit to $226 million.
Read MoreCredit Suisse expects Ramsay Healthcare should be a beneficiary of a volume tailwind post covid and its $69 target price and Neutral credit rating.
Read MoreAPRA data has revealed benefits paid to private hospitals declined -3.3% in the December quarter. UBS retains a Neutral rating and $69.90 target.
Read MoreUBS expects operating earnings in the first half of $971m, down -8%. The broker retains a Neutral rating and reduces the target to $69.90 from $71.20.
Read MoreNo joy at Tuesday’s AGM for shareholders in Ramsay Health Care as demanded to know when they can expect the company to resume paying dividends.
Read MoreAfter a trading update by Ramsay Health Care, Morgans believes the near-term outlook is increasingly challenged as the pandemic makes forecasting difficult.
Read MoreRamsay Health Care does not expect a substantial increase in activity going forward, amid a subdued recovery in Australian surgical admissions. Europe is unlikely to contribute to earnings growth in FY21.
Read MoreWith Alphinity celebrating its 10th anniversary we have explored what has happened in the healthcare sector in the decade since Alphinity was first established.
Read MoreUBS notes larger private hospitals and not standalone day hospitals dominate when it comes to day stay services. The broker highlights according to data from 2019, of the circa $10bn paid by private health insurers to private hospitals, about 21% went to fund day stays out of which the share of day admissions within private hospitals was about 16%.
Read MorePopulation growth forecasts were revised down over 2021-23 in the federal budget as a result of declining net overseas migration (border closures) and a declining fertility rate with families delaying having children amid the uncertainty associated with covid-19.
Read MoreUBS has quantified the volume of non-urgent elective surgery that was likely deferred across Australia during the peak of the pandemic-related restrictions.
Read MorePublic hospital elective surgery data for the four major states indicates, in aggregate, the number of people waiting surgery increased 9% in the March quarter.
Read MoreStrong support from its retail shareholder base for Ramsay Health Care’s $1.4 billion fundraisings which is now $1.5 billion.
Read MorePrivate hospitals group, Ramsay Healthcare is looking to raise a lot of money – $1.4 billion – very quickly, confirmation that the fallout from the COVID-19 pandemic is hitting every sector of the economy.
Read MoreThe broker has looked at the SARS event to provide a guide to when elective surgery may be able to start up again, but the problem is SARS was all over quite quickly and thus provides little precedent for Covid-19.
Read MoreWhile the impact of the pandemic on Ramsay Health Care’s hospital income is uncertain most brokers agree, for the longer term, the hospitals are quality assets, catering to the demands of an ageing population.
Read MoreYesterday saw a host of downgrades and other poor news from ASX companies of all sizes – all understandable in the current terrible investment climate as the combination of the coronavirus pandemic and the idiotic price war in oil between Russia and Saudi Arabia wreck market confidence and share price.
Read MoreRamsay’s UK NHS admissions rose 1.8% year on year in August — a good result, the broker notes, given an 8.0% increase in FY19 — however 12-month rolling growth eased to 3.0% from 3.4%. Current admissions and a tariff increase bode well for NHS revenue in FY20, but the increased use of agency nurses to handle the workload reduces margin expectations, the broker points out.
Read MoreThe outlook for private hospital volumes and prices remains the key driver of Ramsay Health Care, UBS assesses. Australia represents around 78% of the FY20 earnings (EBIT) forecast.
Read MoreSince the beginning of August the stock has underperformed the healthcare sector by -11% and the broader market by -9%, Credit Suisse observes.
Read More